z-logo
Premium
Reply to direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?
Author(s) -
Li Darrick K.,
Chung Raymond T.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29650
Subject(s) - medicine , tolerability , hepatocellular carcinoma , hepatitis c , intensive care medicine , hepatitis c virus , pegylated interferon , oncology , ribavirin , immunology , virus , adverse effect

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom